| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |